Price to Book Value Chart

View Price to Book Value for DERM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Price to Book Value Chart
Start Trial

Historical Price to Book Value Data

View and export this data back to 2021. Start Trial.
Date Value
September 11, 2026 6.227
September 10, 2026 6.106
September 09, 2026 6.416
September 08, 2026 6.864
September 04, 2026 6.769
September 03, 2026 6.804
September 02, 2026 6.692
September 01, 2026 6.519
August 31, 2026 6.382
August 28, 2026 6.433
August 27, 2026 6.485
August 26, 2026 6.498
August 25, 2026 6.485
August 24, 2026 6.812
August 21, 2026 6.674
August 20, 2026 6.450
August 19, 2026 5.865
August 18, 2026 5.736
August 17, 2026 5.564
August 14, 2026 5.787
August 13, 2026 5.727
August 12, 2026 5.538
August 11, 2026 5.443
August 10, 2026 5.546
August 07, 2026 5.538
Date Value
August 06, 2026 5.624
August 05, 2026 5.512
August 04, 2026 5.512
August 03, 2026 5.572
July 31, 2026 5.486
July 30, 2026 5.555
July 29, 2026 5.296
July 28, 2026 5.434
July 27, 2026 5.486
July 24, 2026 5.331
July 23, 2026 5.667
July 22, 2026 6.132
July 21, 2026 6.296
July 20, 2026 6.106
July 17, 2026 6.166
July 16, 2026 6.123
July 15, 2026 6.261
July 14, 2026 6.132
July 13, 2026 5.908
July 10, 2026 5.951
July 09, 2026 6.028
July 08, 2026 5.753
July 07, 2026 5.809
July 06, 2026 6.218
July 02, 2026 6.106

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
Nektar Therapeutics 2.586
ANI Pharmaceuticals, Inc. 2.706
Corcept Therapeutics, Inc. 17.08
Veru, Inc. 1.424
Johnson & Johnson 7.548

Price to Book Value Related Metrics

PS Ratio 2.901
Price 7.40
Earnings Yield -3.13%
Market Cap 204.66M